Evidence map›Paper›PMID 37091129›Full record

ArticleProcedia CIRP2023

Single Use Personal Protective Equipment Reinforced Asphalt.

Marco Marconi, Daniele Landi, Edoardo Bocci, Giorgia Pietroni, Enrico Maria Mosconi

Abstract read
In one paragraph

Article in Procedia CIRP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marco MarconiDepartment of Economics, Engineering, Society and Business Organization, Università degli Studi della Tuscia, Largo dell'Università, 01100 Viterbo, Italy.
Daniele LandiDepartment of Management, Information and Production Engineering, Università degli Studi di Bergamo, Via Pasubio 7/b, 24044 Dalmine (BG), Italy.
Edoardo BocciFaculty of Engineering, Università eCampus, Via Isimbardi 10, 22060 Novedrate (CO), Italy.
Giorgia PietroniDepartment of Economics, Engineering, Society and Business Organization, Università degli Studi della Tuscia, Largo dell'Università, 01100 Viterbo, Italy.
Enrico Maria MosconiDepartment of Economics, Engineering, Society and Business Organization, Università degli Studi della Tuscia, Largo dell'Università, 01100 Viterbo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the COVID-19 pandemic, global personal protective equipment (PPE) volume production and demand increased by 300-400% between 2019 and 2021. In this scenario, the present study aims to propose and validate an innovative circular economy scenario for end of life (EoL) PPEs, reusing them to produce reinforced bituminous mixtures. Despite that several studies confirmed the possibility of reusing plastic in the asphalt mixtures, none of them investigated the potential of PPEs, highlighting the innovativeness in the scientific panorama. Five different alternatives of EoL PPE mixtures (different products, materials, dosages, etc.) were tested at laboratory scale to verify the technical feasibility of the proposed scenario. The most promising solution resulted to be the mix of gloves and face masks composed by polypropylene, polyethylene, nitrile and lattice at a dosage of 0,5% weight/weight that allowed to produce bituminous mixtures with acceptable performances in terms of relevant mechanical parameters while recycling waste PPEs. This leads to environmental benefits, since more than 3kg of EoL PPEs per square meter of road pavement can be reused instead of disposed (about 1,5 million tons/year considering the bituminous mixtures produced at European level), as well as economic benefits for public administrations and the collectivity, due to the reduced landfilling of solid wastes.

Indexed as

Circular economyPersonal protective equipmentReinforced asphaltReuse

Identifiers

PMID37091129
PMCPMC10110394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.